A recent study has shown that transplanting new inhibitory neurons may repair damaged brain circuits.
List view / Grid view
Filter the results
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
New cell experiments show more effective genetic 'cuts' that could one day become the foundation of more effective gene therapies.
An AAV-delivered gene therapy has demonstrated success in animal models of temporal lobe epilepsy, so could be a therapeutic option for human patients.
Researchers in the US have successfully produced a mouse model with a human MAPT gene to enable more accurate research into Alzheimer’s therapy.
Gene therapy for the treatment of Duchenne muscular dystrophy has safely stopped the muscle deterioration associated with the disease.
A study has demonstrated how to use CRISPR to deliver DNA to particular bacteria, which could be used as an alternative to antibiotics.
A study has revealed that using DNA-like molecules to repair gene mutations in models could act as a successful therapy for patients.
A study has shown that CRISPR can be used as a regenerative technique to treat Duchenne muscular dystrophy, which could be developed as a therapeutic option for humans.
We are on the precipice of realising the true potential of genomics studies. Following completion of the Human Genome Project six years ago, huge strides have been made in understanding how the genome works, shedding light on disease pathogenesis and forging therapeutic efforts. In this article, Pushpanathan Muthuirulan explains how…
Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.
This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing.
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.
A study has used CRISPR-Cas9 to treat obesity and type 2 diabetes symptoms in mice, highlighting the potential use in humans.